Patent details

EP1745136 Title: METHOD FOR ENZYMATIC PREPARATION OF (S)-3-CYANO-5-METHYLHEXANOIC ACID

Basic Information

Publication number:
EP1745136
PCT Application Number:
PCT/IB/2005/000873
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057183477
PCT Publication Number:
WO/2005/100580
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHOD FOR ENZYMATIC PREPARATION OF (S)-3-CYANO-5-METHYLHEXANOIC ACID
French Title of Invention:
PROCÉDÉ POUR LA PRÉPARATION DU L'ACIDE 3-CYANO-5-MÉTHYLHEXANOIQUE
German Title of Invention:
VERFAHREN ZUR ENZYMATISCHEN HERSTELLUNG VON (S)-3-CYANO-5-METHYLHEXANSÄURE
SPC Number:

Dates

Filing date:
01/04/2005
Grant date:
07/10/2009
EP Publication Date:
07/10/2009
PCT Publication Date:
27/10/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/01/2007
EP B1 Publication Date:
07/10/2009
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/04/2018
Expiration date:
01/04/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/04/2005
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, CT 06340-5146, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
07/10/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WEAVER Justin Kaine
Address:
United States (US)

2

Name:
WONG John Wing
Address:
United States (US)

3

Name:
BURNS Michael Paul
Address:
United States (US)

Priority

Priority Number:
562133 P
Priority Date:
14/04/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
C12P 13/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
04/04/2017
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
30/08/2018 Outgoing Correspondence 1